Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr1039 Inhibitors

Olfr1039 is a gene that encodes a member of the olfactory receptor family, specifically a G protein-coupled receptor (GPCR) involved in the sense of smell. GPCR inhibitors, like those listed, function by modulating the activity of G protein-coupled receptors, which are integral in numerous physiological processes. This chemical class is diverse, as GPCRs respond to a wide range of ligands and are involved in various signaling pathways. These compounds work by binding to GPCRs, preventing their activation by natural ligands. This blockade can either be competitive, where the inhibitor competes with the natural ligand for the binding site, or non-competitive, where the inhibitor binds to a different site, altering the receptor's conformation and preventing its activation. The inhibition of GPCRs can lead to a decrease in intracellular signaling cascades, which are typically mediated by secondary messengers like cAMP (cyclic adenosine monophosphate), inositol triphosphate (IP3), and diacylglycerol (DAG).

Given the ubiquity of GPCRs in the human body, these inhibitors have wide-ranging effects. The diversity of GPCR subtypes leads to a correspondingly diverse array of inhibitors, each tailored to specific receptors. Ongoing research in this field focuses on increasing the selectivity and efficacy of these inhibitors, along with reducing adverse effects. In summary, while direct inhibitors of Olfr1039 are not well-documented, the modulation of GPCR signaling pathways through the above-mentioned chemicals presents an indirect approach to influencing the activity of this olfactory receptor.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

A non-selective beta-adrenergic receptor antagonist that can modulate GPCR signaling.

Carvedilol

72956-09-3sc-200157
sc-200157A
sc-200157B
sc-200157C
sc-200157D
100 mg
1 g
10 g
25 g
100 g
$124.00
$240.00
$530.00
$999.00
$1530.00
2
(1)

A non-selective beta-blocker and alpha-1 blocker, influencing GPCR-mediated pathways.

Yohimbine hydrochloride

65-19-0sc-204412
sc-204412A
sc-204412B
1 g
5 g
25 g
$51.00
$171.00
$530.00
2
(1)

An alpha-2 adrenergic receptor antagonist, it can alter GPCR-mediated neurotransmission.

Losartan

114798-26-4sc-353662
100 mg
$130.00
18
(1)

An angiotensin II receptor antagonist, affecting GPCR-related pathways.

Ondansetron

99614-02-5sc-201127
sc-201127A
10 mg
50 mg
$82.00
$333.00
1
(0)

A selective 5-HT3 receptor antagonist, modulating GPCR-mediated neurotransmission.

Ipratropium bromide

22254-24-6sc-203606
100 mg
$85.00
3
(0)

A muscarinic acetylcholine receptor antagonist, it influences GPCR pathways.

Clozapine

5786-21-0sc-200402
sc-200402A
sc-200402B
sc-200402C
50 mg
500 mg
5 g
10 g
$69.00
$364.00
$2500.00
$4100.00
11
(1)

An antagonist for various dopamine and serotonin receptors, impacting GPCR pathways.

Haloperidol

52-86-8sc-507512
5 g
$190.00
(0)

A dopamine receptor antagonist, it influences GPCR-mediated signaling.

Risperidone

106266-06-2sc-204881
sc-204881A
sc-204881B
sc-204881C
10 mg
50 mg
1 g
5 g
$174.00
$719.00
$1020.00
$2040.00
1
(1)

An antagonist for serotonin and dopamine receptors, affecting GPCR signaling.